RELYVRIO FDA approval date

The FDA approved RELYVRIO on 29 Sep 2022.

FDA approval date
29 Sep 2022

Drug identity has not yet been verified against registry records

Also recorded as SODIUM PHENYLBUTYRATE; TAURURSODIOL

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2022-09-29DayRELYVRIOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA216660", "applicant_as_listed_by_fda": "AMYLYX", "brand_names": ["RELYVRIO"], "active_ingredients": ["SODIUM PHENYLBUTYRATE", "TAURURSODIOL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20220929", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026